Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06015880 |
| Title | Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | National Cancer Institute (NCI) |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| City of Hope Comprehensive Cancer Center LAO | RECRUITING | Duarte | California | 91010 | United States | Details |
| City of Hope Comprehensive Cancer Center | RECRUITING | Duarte | California | 91010 | United States | Details |
| University of California Davis Comprehensive Cancer Center | RECRUITING | Sacramento | California | 95817 | United States | Details |
| Northwestern University | RECRUITING | Chicago | Illinois | 60611 | United States | Details |
| University of Oklahoma Health Sciences Center | RECRUITING | Oklahoma City | Oklahoma | 73104 | United States | Details |
| University of Virginia Cancer Center | RECRUITING | Charlottesville | Virginia | 22908 | United States | Details |